LP INFORMATION has made a brilliant attempt to elaborately and meticulously analyze the global Needle-free Injection Systems market in its latest report. All of the market forecasts presented in the report are authentic and reliable.
The Needle-free Injection Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
As the global economy mends, the 2021 growth of Needle-free Injection Systems will have significant change from previous year. According to our (LP Information) latest study, the global Needle-free Injection Systems market size is USD million in 2022 from USD 195.7 million in 2021, with a change of % between 2021 and 2022. The global Needle-free Injection Systems market size will reach USD 280.7 million in 2028, growing at a CAGR of 5.3% over the analysis period.
Global Needle-free Injection Systems Market: Market segmentation
Needle-free Injection Systems market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Request Sample Report and Full Report TOC:
https://www.lpinformationdata.com/reports/184379/needle-free-injection-systems-2028
Global Needle-free Injection Systems Market: Regional Segmentation
To understand the changing political scenario, analysts have regionally segmented the market. This gives an overview of the political and socio-economic status of the regions that is expected to impact the market dynamic.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Top Players of Global Needle-free Injection Systems Market are Studied:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Market Segment by Type,can be divided into:
Reusable Injector
Single-use Injector
Market Segment by Applications, covers:
Vaccine Delivery
Insulin Delivery
Others
Contact US
LP INFORMATION
E-mail: [email protected]
Tel: 001-626-346-3938 (US) 00852-58080956 (HK) 0086 15521064060 (CN)
Add: 17890 Castleton St. Suite 369 City of Industry, CA 91748 US
Website: https://www.lpinformationdata.com/
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023Market Highlights:The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to high prevalence of diabetes and chronic diseases.
Increasing use of these injections by patients owing to its accurate dosage, pain relief, and low risks can lead to high market demand in the coming years.
But high costs of these medical devices can pose a challenge to market growth.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6180Global Market for Needle Free Injection – Segmental AnalysisMRFR’s report offers a detailed segmental analysis of the market based on product, technology, usability, type of medication, site of delivery, application, and end-user.
The liquid-based segment held a large share of the market in 2017.
The intramuscular segment is touted to generate maximum revenue for the needle free injection market owing to muscles absorbing vaccines at a much higher rate as compared to veins.Applications include oncology, vaccination, and insulin delivery.
Major market end-users include hospitals and clinics, ambulatory surgical centers, and homecare settings.
The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to a high prevalence of diabetes and chronic diseases.
Market Research Future’s (MRFR) latest study reveals that the market is predicted a 15.28 % CAGR during the forecast period (2018–2023).
Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium.
By product type, the market has been segmented into fillable and prefilled needle free injectors.
Technologies covered in the report include laser-powered, jet-based, and spring-based.
Among these, the jet-based segment can touch a size of USD 10,391.3 million by 2023 owing to a faster method of delivery as compared to other technologies.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.Key Factors Driving Market Growth:The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Revenue Growth Analysis:Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.
Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Based on the end user, the market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.Market DynamicsGrowing Prevalence of Chronic DiseasesIncreasing Incidence of Communicable Diseases Due to Needlestick InjuriesRise in Demand for Self-Injection DevicesBased on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.The geographical regions mapped in the report are:1.
